MergerLinks Header Logo

Announced

Completed

Allergan completed the acquisition of Chase Pharmaceuticals from Cipla Ventures for $125m.

Synopsis

Allergan, a global pharmaceutical company, completed the acquisition of Chase Pharmaceuticals, a clinical-stage biopharmaceutical company, from Cipla Ventures for $125m. "We at Chase Pharmaceuticals are passionate about developing and bringing to physicians and their patients profoundly improved Alzheimer's disease treatments. I am very excited that Allergan has recognized the strong clinical value of our development programs and look forward to seeing Allergan apply its leading clinical development and regulatory expertise to bring these potential treatments forward for patients," Douglas Ingram, Chase Pharmaceuticals CEO.

Show Details & Financials

Market Context

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US